I had heard in a prior investment that there are
I had heard in a prior investment that there are difficulties in deciding whose vote to count and who is seen as the owner with the right to vote the shares.
Lets say that the Issued and Outstanding is 1,400,000 shares, but the count of shares is 2,800,000.
How does the system decide who is the real owner.
It is highly likely, in fact guaranteed, that some or even most of my shares were not shares Issued and Sold by NTEK. Some of my shares may very well have been invented by a short. Yet I am a long investor only. Never short. To me, the sytem sold me shares that I have the right to vote.
But NTEK is only prepared to count 1,400,000 shares.
It would appear that the time of the vote is not equal to the kind of announcement and the time of announcement that would cause real shorts to pay whatever price necessary to close out 1,400,000 short shares. These two actions may be part of the same movement, but one precedes the other.
Paul
Nanotech Entertainment Inc. (NTEK) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Hyzon Motors Announces Delisting from Nasdaq Hyzon Motors Inc. is making a significant shift regarding its stock trading status. This U.S. company, known for its commitment to high-performance hydrogen fuel cell technology, has decided to inform Nasdaq Stock Market of its intent to delist its Class A common stock and publicly traded warrants. This move comes as part of...
Continue Reading
Your Gateway to High Returns in Crypto Staking As the digital currency landscape continues to expand, platforms like Keynode.net are leading the charge in offering unprecedented opportunities for investors. For those seeking impressive annual percentage yields (APY) through crypto staking, Keynode.net has emerged as a premier choice. Its user-friendly interface, robust...
Continue Reading
Overview of the Class Action Lawsuit Against Rocket Pharmaceuticals Pomerantz LLP has initiated a class action lawsuit against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) highlighting various concerns regarding the company's business practices. Investors who have suffered losses during the stipulated Class Period should take note of this unfolding situation. Key Details...
Continue Reading
Revitalizing Economic Growth at the 23rd SMDO Conference The 23rd Annual South Metro Development Outlook (SMDO25) Conference stands as a pivotal forum for industry leaders, policymakers, and community stakeholders. It is designed to foster collaboration and tackle some of the most pressing issues faced by the region today. Set against the backdrop of changing federal...
Continue Reading
Strong First Quarter Results for SciBase In the recent interim report, SciBase has showcased an impressive performance for the first quarter of 2025. The medical technology company, renowned for its innovative dermatological solutions, recorded net sales of TSEK 8,856, marking a remarkable increase of 46% from the previous year’s figures. Financial Performance Overview...
Continue Reading